The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

pyrC  -  dihydroorotase

Salmonella enterica subsp. enterica serovar Typhimurium str. LT2

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of pyrC

  • Conformational heterogeneity in the Salmonella typhimurium pyrC and pyrD leader mRNAs produced in vivo [1].
 

High impact information on pyrC

  • In accordance with predictions based on the nucleotide sequence, the results showed that the 5' end of pyrC and pyrD leader mRNA isolated from repressed cultures is folded into a secondary structure, whereas it is largely unstructured in mRNA isolated from derepressed cultures [2].
  • The introduction of either a pyrA or pyrB mutation into a pyrC strain eliminated the observed growth inhibition [3].
  • Additionally, a direct correlation was shown between the severity of growth inhibition of a pyrC auxotroph and the levels of the enzymes that synthesize carbamyl aspartate [3].
  • The nicotinic acid phosphoribosyltransferase locus pncB was located on the Salmonella typhimurium linkage map counterclockwise relative to pyrC [4].
  • Primer extension experiments on RNA from mutant strains that permit manipulation of the CTP and GTP pools showed that pyrC transcription may start at either a cytosine or a guanine residue, 2 bp apart [5].
 

Chemical compound and disease context of pyrC

 

Biological context of pyrC

  • Growth of Salmonella typhimurium pyrC or pyrD auxotrophs was severely inhibited in media that caused derepressed pyr gene expression [3].
  • A comparison of the polypeptides encoded by pyrC-complementing and non-complementing plasmids showed the gene product to have a molecular mass of approximately 37 kDa [7].
  • S1 nuclease mapping indicated that transcription of pyrC is initiated 40 base pairs upstream from the translational start [7].
  • Regulation of pyrC expression in Salmonella typhimurium: identification of a regulatory region [8].
  • Four independently-isolated regulatory mutants, overexpressing pyrC, were found to have point mutations within the symmetry region and, significantly, the mutations occurred in sequences pertaining to either side of the stem of the putative hairpin of the transcript [8].
 

Associations of pyrC with chemical compounds

  • (ii) The expression of pyrC and pyrD is regulated predominantly by a cytidine nucleotide [9].
  • This requirement for arginine was completely suppressed by pyrB mutations and partially suppressed by pyrC and pyrD mutations [10].
 

Other interactions of pyrC

  • The conformation of the leader regions of wild type pyrC and pyrD mRNA has been investigated by chemical and enzymatic probing of RNA isolated from cultures grown in repressing and derepressing conditions [2].
  • Subcloning of a 184-base-pair DNA fragment, which included 118 base pairs upstream from the transcriptional start, and the first eight codons of the pyrC structural gene, into a galK expression vector, established that the pyrC promoter and regulatory region are harbored on this fragment [7].
  • Isolation and characterization of pyrimidine mutants of Salmonella typhimurium altered in expression of pyrC, pyrD, and pyrE [11].

References

  1. Conformational heterogeneity in the Salmonella typhimurium pyrC and pyrD leader mRNAs produced in vivo. Sørensen, K.I. Nucleic Acids Res. (1994) [Pubmed]
  2. Conformational heterogeneity in the Salmonella typhimurium pyrC and pyrD leader mRNAs produced in vivo. Sørensen, K.I. Nucleic Acids Res. (1994) [Pubmed]
  3. Toxicity of the pyrimidine biosynthetic pathway intermediate carbamyl aspartate in Salmonella typhimurium. Turnbough, C.L., Bochner, B.R. J. Bacteriol. (1985) [Pubmed]
  4. Genetic mapping of the Salmonella typhimurium pncB locus. Foster, J.W., Holley, E.A. J. Bacteriol. (1981) [Pubmed]
  5. Dual transcriptional initiation sites from the pyrC promoter control expression of the gene in Salmonella typhimurium. Sørensen, K.I., Neuhard, J. Mol. Gen. Genet. (1991) [Pubmed]
  6. Cluster of genes controlling proline degradation in Salmonella typhimurium. Ratzkin, B., Roth, J. J. Bacteriol. (1978) [Pubmed]
  7. Cloning and structural characterization of the Salmonella typhimurium pyrC gene encoding dihydroorotase. Neuhard, J., Kelln, R.A., Stauning, E. Eur. J. Biochem. (1986) [Pubmed]
  8. Regulation of pyrC expression in Salmonella typhimurium: identification of a regulatory region. Kelln, R.A., Neuhard, J. Mol. Gen. Genet. (1988) [Pubmed]
  9. Control of expression of the pyr genes in Salmonella typhimurium: effects of variations in uridine and cytidine nucleotide pools. Schwartz, M., Neuhard, J. J. Bacteriol. (1975) [Pubmed]
  10. pryB mutations as suppressors of arginine auxotrophy in Salmonella typhimurium. Jenness, D.D., Schachman, H.K. J. Bacteriol. (1980) [Pubmed]
  11. Isolation and characterization of pyrimidine mutants of Salmonella typhimurium altered in expression of pyrC, pyrD, and pyrE. Kelln, R.A., Neuhard, J., Stauning, L. Can. J. Microbiol. (1985) [Pubmed]
 
WikiGenes - Universities